Best of ASCO® Toronto 2024

Friday, June 14, 2024

Event Type: In-Person
Conference Venue: Sheraton Queen St | Toronto, ON
123 Queen St W, Toronto, ON M5H 2M9
Google Maps link

Best of ASCO - Toronto

Event Landscape

OncologyEducation’s Best of ASCO® Toronto 2024 Conference is licensed by the American Society of Clinical Oncology® and will be an all-day event on June 14, 2024.

Chaired by Dr. Natasha Leighl and Dr. Aly-Khan Lalani, the Best of ASCO® Toronto Conference provides oncologists and medical professionals with an expert summary of the most significant research advances, groundbreaking insights, and clinically relevant abstracts presented at the 2024 ASCO® Annual Meeting.

With expert-led sessions focused on multiple cancer types, you’ll learn the latest therapy approaches to enhance your clinical practice and improve patient outcomes.

The Best of ASCO® 2024 Toronto faculty will draw from some of Eastern Canada’s most influential oncologists.

Learning Objectives

  1. Summarize the most significant treatment advances presented at the 2024 ASCO® Annual Meeting.
  2. Describe the current standard of care for key malignancies.
  3. Discuss the current controversies in the management of specific cancers.

Scientific Agenda

Click below to learn more about the scheduled presentations and incredible speaker lineup at the Best of ASCO® Toronto Conference 2024.

Meet the Best of ASCO® Toronto 2024 Conference Co-Chairs

Dr. Natasha Leigh

Dr Natasha Leighl
Medical Oncologist, Professor and Department Head, Queen’s University

Dr Natasha Leighl leads the Thoracic Medical Oncology Group at the Princess Margaret Cancer Centre, and is Professor in the Department of Medicine, and Adjunct Professor in the Institute of Health Policy, Management and Evaluation at the University of Toronto. She holds the OSI Pharmaceuticals Foundation Chair in Cancer New Drug Development through the Princess Margaret Cancer Foundation. She has published over 300 peer-reviewed papers, has held (as principal or co-investigator) over $600 million in peer-reviewed grant funding, and has mentored many oncology trainees that have gone on to leadership roles in oncology around the world. Recently, she was awarded the American Society of Clinical Oncology Excellence in Teaching Award (2019).

After receiving her MD from the University of Toronto, Canada, Dr. Leighl completed residencies in internal medicine at the University of Calgary and in medical oncology at the University of Toronto. She subsequently completed a Fellowship in Thoracic Oncology with Dr. Frances Shepherd at the Princess Margaret Hospital in Canada, a Fellowship in Clinical Oncology with Prof. Martin Tattersall at the University of Sydney in Australia, and received her Masters in Medical Science (MMSc) in Clinical Epidemiology at the University of Newcastle, Australia.

Dr. Aly-khan Lalani

Dr. Aly-khan Lalani

Dr. Lalani is an Assistant Professor at McMaster University and Chair for the GU Cancers Disease Site Team at the Juravinski Cancer Centre. He pursued a Fellowship in GU Oncology at Dana-Farber Cancer Institute in Boston, and completed the Program in Clinical Effectiveness at the Harvard T.H. Chan School of Public Health. His academic interests include clinical trial design and translational work for GU malignancies. He was awarded the Elizabeth Eisenhauer Early Drug Development Young Investigator Award 2022 from the CCTG, and the Rising Star award from CAMO in 2023. He is the lead PI for the CYTOSHRINK clinical trial.

Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at [email protected] for registration and sponsorship opportunities. Industry registrations will not be accepted through the website.


​For sponsorship-related inquiries, please contact Bernadette Gregoris at [email protected].

Best of GU&GI Cancers conference 2024 Sponsors

Platinum sponsor

Gold sponsors

Ipsen logo

Silver sponsor

Seagen Logo
All sales are final, refunds will not be accepted.

Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.

Register Now